podophyllotoxin has been researched along with theasinensin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arena, A; Benedetti, R; Cirone, M; D'Orazi, G; Gilardini Montani, MS; Romeo, MA | 1 |
1 other study(ies) available for podophyllotoxin and theasinensin a
Article | Year |
---|---|
VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; DNA Damage; Down-Regulation; Doxorubicin; HSP70 Heat-Shock Proteins; Humans; Pancreatic Neoplasms; Phenols; Phthalazines; Piperidines; Podophyllotoxin; Poly(ADP-ribose) Polymerase Inhibitors; Rad51 Recombinase | 2022 |